BRD2 and hypogonadotropic hypogonadism: In patients of pubertal age with untreated congenital central hypogonadism, serum AMH is elevated for age—because the insufficient testosterone production is unable to downregulate AMH, but lower than expected for patient's Tanner stage [23, 24]—reflecting the lack of FSH stimulus.